#PCRLV, valve hemodynamics, concerns and data @PCRonline

#PCRLV, got some challenging cases concerning coronary patency in VIV？Leaflet modification techniques are to help. @PCRonline @PamelaGatto @dr_chrisallen @O_Azizy_MD @BenekiEirini @MiChen__ @CurioJonathan @juliendreyfus1 @jcecharte @cvnurselin @drtsakamoto @Omar_A_Oliva

#PCRLV, TAVR in pure aortic regurgitation. Ready to treat this different disease? @PCRonline @dr_chrisallen @O_Azizy_MD @BenekiEirini @MiChen__ @CurioJonathan @juliendreyfus1 @jcecharte @DrGarot @drtsakamoto @a_sorropago @TagliariPaula @m_taramasso

#TAVI for aortic regurgitation in high surgical risk: Outcomes in 700 patients from ALIGN-AR Following his presentation during the LBTs session at #PCRLV, ⁦@dr_tyxiong⁩ interviews Raj Makkar to share the take home messages from the ALIGN-AR trial.

#PCRLV, packed room for the sharing of treating BAV stenosis. What are your concerns of TAVR in BAV in your daily practice? @dr_chrisallen @Omar_A_Oliva @PCRonline

3 days to go, and 4,000 participants are already set for #PCRLV! 🌍 From every corner of the world, the Heart Team unites in London with one goal: better patient care. 🗓️ Be part of it | 16-18 Nov 2025 https://t.co/RR76J5597e @drmaisano @drtpatterson @nicolo_piazza

The best ideas happen face-to-face: 3,300 of your peers know this and have already registered for #PCRLV! Will you join them in London? Imagine connecting with the whole Heart Team and working together to drive patient care forward: https://t.co/rHN7Hzd8DA